Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENN0403 in Diabetic Macular Edema
NCT06708260Phase 2Completed
- Sponsor
- EnnovaBio
- Start
- Dec 2024
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ENN0403 in diabetic macular edema (DME), sponsored by EnnovaBio. Started Dec 2024; status: completed.
02
Drugs
ENN0403
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT06708260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06708260.